Clinical Trial Update: Inhaled NO in IPF and COPD During 6 Minute Walk Test [Phase 2]

View source ↗

Summary

Phase 2 trial exploring inhaled nitric oxide effects in COPD and idiopathic pulmonary fibrosis during the six-minute walk test.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Rabin Medical Center | Conditions: COPD, IPF | Phase 2 | Status: UNKNOWN